ECO Animal Health Announces Head of Global R&D Departure
The healthcare company announces the departure of its Head of Global R&D, with the search for a replacement underway.
The healthcare company announces the departure of its Head of Global R&D, with the search for a replacement underway.
The healthcare company reports a robust first half, with revenue growth exceeding 15% and improved profitability.
The healthcare company has appointed a new joint broker to work alongside its existing nominated adviser and joint broker.
The healthcare company has granted share awards to its Chief Executive Officer and Chief Financial Officer under its long-term incentive and deferred bonus plans.
The animal health company has announced the posting of its annual report and notice of the upcoming AGM.
The healthcare company has announced a shareholder update, providing details on its current holdings.
The retailer has announced a major shareholder disclosure, providing details on the shareholding changes.
The retailer's Chief Executive Officer has purchased additional shares in the company.
The animal health company reported a revenue decline and acknowledged challenging market conditions, despite some improvements in profitability and margins. Management highlighted ongoing headwinds and economic uncertainties affecting performance.
The animal health company has announced a general meeting and the date for its annual results release.